What is Bafna Pharmaceuticals Limited (BAFNAPH) share price today?

Bafna Pharmaceuticals Limited (BAFNAPH) is listed on the NSE. Visit VestAI at https://www.vestai.io/stocks/BAFNAPH for the latest live price, technical analysis, and AI-powered insights.

How to analyse BAFNAPH stock?

VestAI provides comprehensive BAFNAPH stock analysis including RSI, MACD, Bollinger Bands, SMA trend, ROCE, debt-to-equity ratio, and smart money holdings by superstar investors.

What sector is Bafna Pharmaceuticals Limited in?

Bafna Pharmaceuticals Limited (BAFNAPH) is in the Healthcare sector, Pharmaceuticals industry on the NSE.

Bafna Pharmaceuticals Limited

BAFNAPH

NSE· Healthcare

₹165.86

-8.72 (-4.99%)

Updated 01:36 pm IST

52W Low · ₹78.1852W High · ₹193.97

Near 52W High

Market Cap

₹484.03L Cr

Volume

24.8K

Prev Close

₹208.70

ISIN

INE878I01022

VestAI Stock Score

VALUATION

Low Debt

D/E 0.39x — lean balance sheet

QUALITY

Low Quality

ROCE 8.3% — poor capital efficiency

MOMENTUM

Neutral

RSI 70.6 — consolidating

Price Chart

SMA 20

SMA 50

SMA 200

Key Fundamentals

Q4 FY2026

P/E Ratio: 43.63
ROCE: 8.34%
ROE (1Y): 12.27%
D/E Ratio: 0.39x
OPM: 4.47%
TTM EPS: ₹4.69
Dividend Yield: 0.00%
Qtrly Sales: ₹42.24 Cr
Qtrly Profit: ₹2.75 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit

Quarter	Revenue	Net Profit	OPM	EPS
Q3 2026	₹38.29	₹1.84	3.9%	₹0.78
Q2 2026	₹35.47	₹3.12	7.9%	₹1.32
Q1 2026	₹34.62	₹3.39	10.7%	₹1.43
Q4 2025	₹39.06	₹1.31	9.1%	—
Q3 2025	₹33.19	₹0.95	4.3%	₹0.40

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit

Year	Revenue	Net Profit	EBITDA	OPM
FY 2025	₹145.86	₹4.15	₹11.6	4.8%
FY 2024	₹152.47	₹7.35	₹14.28	4.3%
FY 2023	₹115.35	₹11.34	₹18.75	10.5%
FY 2022	₹85.14	₹5.22	₹11.23	7.8%

Peer Comparison — Healthcare

Top companies in the same sector by market cap

Company	Mkt Cap	P/E	ROCE	ROE	D/E	OPM
BAFNAPH ★	₹484 Cr	43.63	8.34%	12.27%	0.39x	4.47%
SUNPHARMASun Pharmaceutical Industries	₹4,27,609 Cr	37.32	15.73%	14.72%	0.06x	18.90%
MAXHEALTHMax Healthcare Institute	₹95,110 Cr	66.21	11.94%	14.33%	0.32x	22.56%
AUROPHARMAAurobindo Pharma Limited	₹90,029 Cr	25.94	12.55%	9.93%	0.21x	15.11%
ABBOTINDIAAbbott India Limited	₹57,724 Cr	36.63	36.14%	34.46%	0.04x	27.01%
AJANTPHARMAjanta Pharma Limited	₹41,836 Cr	39.55	27.99%	25.39%	0.06x	51.40%

Balance Sheet

All values in ₹ Crores

Metric	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	₹153.08	₹147.68	₹129.58	₹90.14
Equity	₹84.81	₹80.84	₹73.45	₹61.96
Total Debt	₹28.2	₹24.39	₹22.92	₹11.06
Cash	₹3.43	₹1.4	₹7.81	₹0.02
Net Debt	₹24.77	₹22.99	₹15.11	₹11.04
Working Capital	₹32.88	₹39.69	₹40.84	₹28.87

Shareholding Pattern

Q1 FY2027

Promoter

90.22%

FII

DII

Public

9.78%

Quarter-over-Quarter Trend

Quarter	Promoter	FII	DII	Public
Q1 FY2027	90.22%	0%	0%	9.78%
Q4 FY2026	90.22% ↑	0% ↓	0%	9.78% ↓
Q3 FY2026	75%	9.34%	—	15.66%
Q2 FY2026	75%	9.34%	—	15.66%
Q1 FY2026	75%	9.34% ↑	—	15.66% ↓
Q4 FY2025	75% ↓	8.53% ↑	—	16.47% ↑
Q3 FY2025	88.29%	0%	—	11.7%
Q2 FY2025	88.29%	0%	—	11.7%

Corporate Actions

No recent corporate actions

Analyse BAFNAPH with Orion AI

Ask: "Is Bafna Pharmaceuticals Limited stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About Bafna Pharmaceuticals Limited (BAFNAPH) Stock

Bafna Pharmaceuticals Limited is listed on the NSE under the Healthcare sector, Pharmaceuticals industry. ISIN: INE878I01022. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.